Nuvectis Pharma Inc.
NVCT | NASDAQ
$21.98
-$0.02 (-0.09%)
At close: Sep 21, 2026, 4:00 PM ET
$21.98
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:10 PM ET
Market Data
Market Cap $583.27M
Enterprise Value $561.11M
Beta -0.26
Average Volume 265.24K
Shares Outstanding (Diluted) 23.48M
Shares Change YoY 9.87%
Institutional Ownership 19.30%
Exchange NASDAQ
ISIN US67080T1088
Price Performance
Price Change 1M -9.6%
Price Change 3M 25.2%
Price Change 6M 176.1%
Price Change YTD 158.3%
Price Change 1Y 241.8%
Price Change 3Y 57.7%
Price Change 5Y 576.3%
1M CAGR (ann.) 16.0%
1Y CAGR (ann.) 243.4%
5Y CAGR (ann.) N/A
All-Time CAGR 51.1%
Valuation
PE Ratio -16.78
Forward PE N/A
PEG Ratio 1.12
Forward PEG -1.62
PS Ratio N/A
Forward PS 22.40
PB Ratio 64.22
P/FCF Ratio -22.42
P/Adj. FCF Ratio -16.97
P/OCF Ratio -26.48
EV/Sales N/A
EV/EBIT -19.40
EV/EBITDA -19.40
EV/FCF -21.56
Earnings Yield -6.0%
FCF Yield -4.5%
Adj. FCF Yield -5.9%
Financial Health
Net Cash $22.16M
Total Debt $0
Cash & Short-Term Investments $22.16M
Total Assets $22.38M
Current Ratio 1.68
Quick Ratio 1.68
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage 0.00
Altman Z-Score 15.49
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -32.1%
Returns
Return on Assets -124.5%
Return on Equity -169.5%
Return on Invested Capital -317.9%
Return on Capital Employed -317.9%
Return on Tangible Assets -124.5%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y -0.4%
EPS CAGR 5Y 1.5%
EPS CAGR 10Y N/A
FCF CAGR 3Y -32.8%
FCF CAGR 5Y -15.7%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 3
EPS Growth Next 3Y 27.2%
Revenue Growth Next 3Y N/A
Earnings Date Nov 2, 2026
EPS Estimate (next Q) -$0.22
EPS Growth Est (next Q) -50.0%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $37.33
Price Target Upside 69.8%
Cash Flow
Operating Cash Flow $-26.02M
Free Cash Flow $-26.02M
Adj. Free Cash Flow $-34.36M
FCF Per Share -$0.83
OCF Per Share -$0.83
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $0
Operating Income $-28.87M
EBITDA $-28.92M
Net Income $-27.85M
EPS (Diluted) -$1.31
Revenue / Employee N/A
Profit / Employee $-1.74M
Employees 16
Add to Watchlist
Select watchlists to add or remove NVCT